The global expansion of life expectancy brings new clinical realities for gender-diverse populations who require long-term healthcare. Historically, healthcare systems overlooked the complex biological and psychosocial needs of aging transgender adults. Many older individuals navigated years of social stigma, systemic healthcare discrimination, and variable access to medical interventions. Consequently, clinicians frequently encounter significant diagnostic and therapeutic dilemmas when managing these individuals later in life. Medical providers often lack robust evidence regarding chronic hormonal treatments and age-associated comorbidities. To resolve these uncertainties, researchers conducted a modified Delphi consensus study to identify crucial clinical and research priorities. This groundbreaking collaborative effort establishes a clear roadmap for patient-centered geriatric medicine.

Clinical Imperatives for Aging Transgender Adults

Older gender-diverse patients face distinct clinical challenges that intersect biological aging with the lifelong consequences of chronic minority stress. Therefore, primary care clinicians and geriatric specialists must cultivate specialized cultural competence alongside rigorous diagnostic precision. The modified Delphi study established that provider knowledge regarding older transgender individuals represents the single most urgent clinical priority. Currently, substantial deficits in formal medical curricula leave healthcare professionals unprepared to handle routine geriatric evaluations in this population. Furthermore, clinicians must evaluate gender-affirming surgical histories alongside typical age-related changes in prostate, breast, or reproductive anatomy. When physicians lack comprehensive training, patients frequently delay essential primary care screenings or experience avoidable misdiagnoses. In addition, healthcare teams must recognize how decades of societal discrimination exacerbate physical frailty, cardiometabolic disease, and cognitive vulnerability. Establishing an inclusive and respectful clinic environment fosters mutual trust and encourages continuous preventive health visits. Consequently, comprehensive provider education stands as the foundation for safe, effective, and patient-centered geriatric management. Ultimately, closing these knowledge gaps ensures equitable diagnostic assessments and elevates clinical care standards across all medical settings.

Consensus Priorities in Geriatric Transgender Care

The Delphi consensus panel deployed a multi-stage evaluation process involving expert clinicians and a community committee of older transgender individuals. Through this community-engaged approach, the panel systematically rated fifteen clinical and seven research topics. After rigorous multi-round deliberations, experts achieved consensus on critical areas demanding immediate clinical intervention. Foremost among these priorities was the urgent need to assess social isolation, persistent loneliness, and fragile support networks. Many transgender seniors live without traditional family support systems due to historical ostracization. As a result, they rely extensively on chosen families or navigate illness in complete isolation. Additionally, the panel prioritized provider knowledge regarding legal, financial, mental health, and community resources. Physicians cannot treat aging patients effectively while ignoring the legal frameworks that govern medical decision-making and surrogate appointments. Clinicians must actively connect vulnerable patients with affirming home care agencies, community aid, and legal assistance. Furthermore, integrating geriatric assessment tools tailored to gender-diverse realities optimizes multidisciplinary care delivery. By coordinating medical management with comprehensive social support, healthcare teams can prevent unplanned hospital admissions and support dignified aging in place.

Hormone Therapy Management and Biologic Longevity

Gender-affirming hormone therapy remains a lifelong cornerstone of medical care for many transgender individuals. However, significant research gaps surround the prolonged physiological effects of exogenous sex steroids in geriatric cohorts. The consensus panel appropriately designated the clinical implications of long-term hormone therapy and hormone cessation as a paramount research priority. Clinicians currently navigate conflicting opinions regarding whether to taper, maintain, or discontinue estradiol or testosterone regimens in elderly patients. Indiscriminate hormone cessation often produces profound psychological distress, dysphoria, and bone mineral density loss. Conversely, continuing therapy may influence venous thromboembolism, cardiovascular morbidity, and hormone-sensitive malignancies. In addition, the Delphi experts emphasized the necessity of investigating the biologic mechanisms linking hormone therapy to cellular aging, vascular stiffness, and metabolic dysfunction. Understanding these biological pathways will help endocrinologists personalize dosing regimens according to individual cardiovascular and oncologic risk profiles. Consequently, longitudinal observational studies must track aging cohorts over decades. Such clinical evidence will empower physicians to balance oncologic safety against psychosocial well-being, preserving quality of life without compromising patient safety.

Addressing Psychosocial Isolation and Structural Vulnerabilities

Beyond biological considerations, social determinants of health exert a profound influence on the life expectancy of older transgender individuals. Throughout their lives, many older adults faced employment discrimination, unstable housing, and inadequate retirement security. Therefore, healthcare teams must screen systematically for financial instability, housing insecurity, and food scarcity during routine clinical encounters. The Delphi findings highlight the critical importance of clinic-level awareness of community social and legal services. Moreover, institutionalized healthcare settings such as nursing homes and assisted living facilities frequently present hostile or uneducated environments. Many transgender elders express legitimate fears of mistreatment, neglect, or forced detransition upon entering long-term residential care facilities. Consequently, geriatricians and social workers must advocate for institutional protective policies and inclusive facility standards. Providers should also encourage patients to formulate advance directives, durable power of attorney designations, and gender-affirming living wills early. Proactively establishing these legal protections guarantees that surrogate decision-makers respect the patient's affirmed gender identity, anatomical preferences, and chosen family members during acute medical crises.

Implications for Clinical Practice and Future Guidelines

The insights gathered through this modified Delphi consensus provide an indispensable blueprint for modernizing geriatric clinical practice. Medical schools and postgraduate training bodies must integrate gender-affirming geriatric medicine into standardized medical curricula immediately. By doing so, healthcare institutions can eliminate provider bias and build a knowledgeable workforce ready to serve diverse aging populations. Furthermore, clinical societies must collaborate to publish evidence-based practice guidelines that address the unique interface between aging and transgender care. Clinicians should adopt multidimensional evaluation protocols that encompass routine chronic disease screening, bone density assessments, polypharmacy reconciliation, and cognitive evaluations. Simultaneously, interdisciplinary clinics should establish direct partnerships with community-based advocacy groups. Such partnerships bridge the gap between clinical settings and community resources, empowering patients to access available legal and financial protections. Moreover, future clinical trials must intentionally recruit older transgender participants to investigate age-related pharmacokinetic changes in hormonal treatments. Ultimately, advancing clinical education, patient-centered research, and protective institutional policies will ensure that older transgender individuals receive the comprehensive, dignified, and evidence-informed care they deserve.

How should clinicians manage gender-affirming hormone therapy in older transgender patients?

Clinicians should individualize hormone therapy rather than abruptly discontinuing treatment solely due to advanced age. Abrupt cessation can precipitate severe gender dysphoria, mood instability, and accelerated bone density loss. Therefore, physicians must carefully evaluate cardiovascular risks, venous thromboembolic history, and bone health. Adjusting dosages, switching to transdermal estradiol preparations, and monitoring serum hormone concentrations allow clinicians to maintain gender affirmation safely while effectively minimizing potential age-related medical complications and chronic disease risks.

Why is screening for social isolation crucial in aging transgender adults?

Screening for social isolation is critical because older transgender individuals frequently lack traditional biological family support systems due to lifelong societal rejection. Consequently, they experience higher rates of loneliness, depression, and delayed medical presentation. Identifying limited social support networks enables clinicians to connect patients with affirming community resources, social workers, and peer organizations. These vital interventions help mitigate mental health deterioration, prevent acute caregiver crises, and ensure consistent long-term adherence to essential medical therapies.

What are the primary clinical priorities identified by the Delphi consensus?

The Delphi consensus identified three primary clinical priorities: improving provider knowledge regarding the healthcare needs of older transgender adults, routinely evaluating social isolation and support networks, and expanding clinic familiarity with local legal, financial, and mental health resources. Addressing these priorities ensures that clinicians provide culturally competent, holistic medical care. Moreover, this approach tackles both direct clinical conditions and the structural vulnerabilities that significantly undermine healthy aging outcomes in gender-diverse populations.

Disclaimer: This content is for informational and educational purposes only... Refer to the latest local and national guidelines for clinical practice.

References

Lau M et al. A Modified Delphi Process to Identify Clinical and Research Priorities for Aging Transgender Adults. J Am Geriatr Soc. 2026 Oct 15. doi: 10.1111/jgs.70771. PMID: 42876410.

Coleman E, Radix AE, Bouman WP, et al. Standards of Care for the Health of Transgender and Gender Diverse People, Version 8. Int J Transgend Health. 2022;23(Suppl 1):S1-S259.

Ruocco A, Manoli M, Marconi M, Pierdominici M. Navigating aging as transgender and gender diverse individuals: current realities and future public health challenges. A narrative review. J Sex Med. 2025;22(2):112-124.

Hembree WC, Cohen-Kettenis PT, Gooren L, et al. Endocrine Treatment of Gender-Dysphoric/Gender-Incongruent Persons: An Endocrine Society Clinical Practice Guideline. J Clin Endocrinol Metab. 2017;102(11):3869-3903.